-
BMW boosts profitability, welcomes Nexperia signals
-
EU strikes last-ditch deal on climate targets as COP30 looms
-
Stocks retreat as tech bubble fears grow
-
Shein opens first permanent store amid heavy police presence
-
West Indies edge New Zealand despite Santner brilliance
-
French pair released by Iran await return home
-
German factory orders up but outlook still muted
-
Death toll tops 100 as Philippines digs out after typhoon
-
Attack on key city in Sudan's Kordofan region kills 40: UN
-
'No one could stop it': Sudanese describe mass rapes while fleeing El-Fasher
-
Champagne and cheers across New York as Mamdani soars to victory
-
Medieval tower collapse adds to Italy's workplace toll
-
BMW boosts profitability despite China, tariff woes
-
South Africa's Wiese wary of 'hurt' France before re-match
-
Asian markets sink as tech bubble fears grow
-
Beyond limits: Croatian freediver's breathtaking record
-
Tottenham supporting Udogie after alleged gun threat in London
-
Thunder roll Clippers to stay unbeaten as SGA keeps streak alive
-
In appeal, Australian mushroom murderer alleges 'miscarriage of justice'
-
Toyota hikes profit forecasts 'despite US tariffs'
-
Typhoon death toll soars past 90 in the Philippines
-
Ex-France lock Willemse challenges Meafou to become 'the bully'
-
Ukrainians to honour sporting dead by building country they 'died for': minister
-
At least 7 dead after UPS cargo plane crashes near Louisville airport
-
US Supreme Court hears challenge to Trump tariff powers
-
US government shutdown becomes longest in history
-
India's Modi readies bellwether poll in poorest state
-
Green goals versus growth needs: India's climate scorecard
-
Where things stand on China-US trade after Trump and Xi talk
-
Sri Lanka targets big fish in anti-corruption push
-
NY elects leftist mayor on big election night for Democrats
-
Injured Jordie Barrett to miss rest of All Blacks tour
-
Asian markets tumble as tech bubble fears grow
-
Pay to protect: Brazil pitches new forest fund at COP30
-
Australia pick 'impressive' Weatherald in first Ashes Test squad
-
Iraq's social media mercenaries dying for Russia
-
Young leftist Trump foe elected New York mayor
-
Concerns at ILO over expected appointment of close Trump advisor
-
Venus Williams to return to Auckland Classic at the age of 45
-
No deal yet on EU climate targets as COP30 looms
-
Typhoon death toll climbs to 66 in the Philippines
-
NATO tests war preparedness on eastern flank facing Russia
-
Uncapped opener Weatherald in Australia squad for first Ashes Test
-
Liverpool down Real Madrid in Champions League, Bayern edge PSG
-
Van Dijk tells Liverpool to keep calm and follow Arsenal's lead
-
PSG left to sweat on injuries to Dembele and Hakimi
-
Reddit, Kick to be included in Australia's social media ban
-
Ex-Zimbabwe cricket captain Williams treated for 'drug addiction'
-
Padres ace Darvish to miss 2026 MLB season after surgery
-
Diaz hero and villain as Bayern beat PSG in Champions League showdown
'Love hormone'? Not so fast, new study suggests
The "love hormone" oxytocin has long been thought key to behaviours including pairing up with a partner and nurturing offspring, but a new study in prairie voles is raising doubts.
The research found that voles bred to lack functioning receptors for oxytocin were still able to form strong pairs, produce young and nurse -- all behaviours previously believed to depend on the hormone.
Prairie voles are one of the few mammals that mate for life, and are often used to study social behaviours like pair-forming in animals.
In past studies, voles given drugs that stopped oxytocin being processed no longer formed pairs, and mothers failed to produce milk for their young.
Psychiatrist Devanand Manoli and neurobiologist Nirao Shah produced genetically altered prairie voles without working oxytocin receptors, and then observed how the mutant male and female voles behaved.
To their shock, the mutant voles appeared to have no difficulty pairing up with non-genetically altered partners, and mutant females could still deliver and nurse young, unlike those in the drug-driven studies.
"We were certainly surprised," said Manoli, an assistant professor at the University of California, San Francisco.
The results suggest that oxytocin is not the main, or only, driver of activities like partnering or nursing, he said.
"What the genetics reveals is that there isn't a 'single point of failure' for behaviours that are so critical to the survival of the species," he told AFP.
- 'Very complex behaviours' -
That didn't mean there were no differences, however.
Some male mutant voles that paired with ordinary female partners didn't show the aggression towards interloping females that would normally be expected.
And while mutant females produced and nursed litters, some had fewer pups per litter than their counterparts, and fewer of their offspring survived to weaning, the paper published Friday in the journal Neuron explains.
Pups born to mutant mothers also tended to weigh less, suggesting that they were not able to nurse as effectively.
The study only involved pairing of mutant voles with "wild-type" partners, and the researchers said pairings with two mutant partners could produce different results.
Still, as a whole, the findings suggest a different picture of oxytocin's role in several important behaviours.
That could be because animals bred without the receptors developed "other compensatory pathways" that helped them pair up and nurse, said Shah, a professor at Stanford University.
But the researchers suggest it likely means oxytocin is only part of a set of genetic factors that control social behaviour.
"What I think our studies reveal is that there are multiple pathways that regulate these very complex behaviours," said Manoli.
Oxytocin has sometimes been suggested as a way to treat attachment disorders and other neuropsychiatric issues, but there is little settled science on how effective it is.
Now the researchers hope to investigate what other hormones and receptors may be involved in behaviours like pairing and nursing.
"These other pathways might serve as new therapeutic targets," Manoli said.
Z.AbuSaud--SF-PST